Blood Pressure Medications Recalled Contain Unacceptable Level of Cancer-Causing Ingredient
By Radiant Health EditorsPublished: October 24, 2021
Health News Briefs
Two blood pressure drugs, irbesartan tablets and irbesartan and hydrochlorothiazide tablets, are being recalled because they contain higher than acceptable levels of the cancer-causing substance, N-nitrosoirbesartan. Lupin Pharmaceuticals issued the recall voluntarily. So far, only four people have reported illness potentially related to the medicine. The first batches of the affected medicine were distributed in October of 2018. Lupin Pharmaceuticals has been contacting pharmacies, supermarkets, and wholesalers to initiate a return of their recalled products. The company says that anyone who is currently taking the medication should contact their doctor for advice on next steps.
Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.
- How To Reduce Screen Time On Phone: 5 Helpful Strategies To Help You Stay Connected With The Real World - October 30, 2024
- 11 Wellness Gift Ideas: Perfect Presents for Her that Nurture Body, Mind, and Soul - October 13, 2024
- 11 Best Indoor Air Purifying Plants: Nature’s Air Filters for Your Home - September 27, 2024
- 11 Best Health and Wellness Books to Read in 2024 - July 4, 2024
- Some Americans Will Have Medical Debt Wiped From Credit - July 9, 2022
- Natural Gas Used to Heat Homes Contains Some Harmful Chemicals - July 9, 2022
- Uterine Cancer Claims Many Black Lives - July 9, 2022
- Babies and Toddlers Get COVID-19 Shots - June 27, 2022
- FDA Bans Juul’s E-Cigarettes and Cartridges - June 27, 2022
- Polio Virus Found in London Sewage - June 27, 2022